Invention Grant
- Patent Title: Melanoma antigen peptide and uses thereof
- Patent Title (中): 黑素瘤抗原肽及其用途
-
Application No.: US14402803Application Date: 2012-05-22
-
Publication No.: US09573975B2Publication Date: 2017-02-21
- Inventor: Nathalie Labarriere , François Lang , Mathilde Bobinet , Anne Rogel
- Applicant: Nathalie Labarriere , François Lang , Mathilde Bobinet , Anne Rogel
- Applicant Address: FR Paris FR Nantes FR Paris FR Angers
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE NANTES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE D'ANGERS
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE NANTES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE D'ANGERS
- Current Assignee Address: FR Paris FR Nantes FR Paris FR Angers
- Agency: Whitham, Curtis & Cook, P.C.
- International Application: PCT/IB2012/001310 WO 20120522
- International Announcement: WO2013/175256 WO 20131128
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/10 ; A61K38/16 ; A61K38/04 ; C07K7/08 ; A61K39/00 ; C07K14/47
Abstract:
The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
Public/Granted literature
- US20150291660A1 NOVEL MELANOMA ANTIGEN PEPTIDE AND USES THEREOF Public/Granted day:2015-10-15
Information query
IPC分类:
